Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.82 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.82 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Isobutyl Ketone SCHEMBL2240499 | 0.97 | ALDH1A1 (0.78) | ALDH1A1TDP1CA2FFAR3CYP2C19 | |
| Methyl Isobutyl Ketone SCHEMBL1128055 | 0.91 | ALDH1A1 (1.00) | ALDH1A1TDP1CA2CYP2C19SMN1; SMN2 | |
| Methyl Isobutyl Ketone SCHEMBL15458 | 0.91 | — | — | |
| Methyl Isobutyl Ketone SCHEMBL1580340 | 0.91 | — | — | |
| Methyl Isobutyl Ketone SCHEMBL15772913 | 0.89 | ALDH1A1 (0.74) | ALDH1A1TDP1CA2FFAR3CYP2C19 | |
| Methyl Isobutyl Ketone SCHEMBL691876 | 0.89 | TDP1 (0.74) | ALDH1A1TDP1CA2FFAR3CYP2C19 | |
| Methyl Isobutyl Ketone SCHEMBL104272 | 0.88 | ALDH1A1 (0.82) | ALDH1A1TDP1CA2CYP2C19SMN1; SMN2 | |
| Methyl Isobutyl Ketone SCHEMBL9056069 | 0.88 | ALDH1A1 (0.82) | ALDH1A1TDP1CA2CYP2C19SMN1; SMN2 | |
| Methyl Isobutyl Ketone SCHEMBL6387945 | 0.88 | — | — | |
| Methyl Isobutyl Ketone SCHEMBL809423 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200148633-A1 | METHOD FOR PREPARING HYDROGEN BIS(FLUOROSULFONYL)IMIDE AND METHOD FOR PREPARING LITHIUM BIS(FLUOROSULFONYL)IMIDE | Jiujiang Tinci Advanced Materials Co., Ltd. (CN) | 2020-05-14 | — | — | US | claimed |
| CN-104220414-B | Hydrocarboxylation of formaldehyde in the presence of higher carboxylic acids and heterogeneous catalysts | 伊士曼化工公司 | 2016-09-21 | — | — | CN | claimed |
| CN-105296003-A | Solvent deoiling raw material hydrorefining method | SHAANXI SHENGHUIYUAN INFORMATION SCIENCE & TECHNOLOGY CO LTD | 2016-02-03 | — | — | CN | claimed |
| US-8790545-B2 | Composition for liquid crystal film, liquid crystal film using composition, and method of manufacturing liquid crystal film | LG CHEM, LTD. (KR) | 2014-07-29 | — | — | US | claimed |
| CN-102453548-B | Solvent dewaxing method by use of dewaxing assistant | CHINA PETROLEUM & CHEMICAL | 2014-07-23 | — | — | CN | claimed |
| EP-2585048-A1 | COMPOSITIONS OF 5-ETHYL-2-{4-[4-(4-TETRAZOL-1-YL-PHENOXYMETHYL)-THIAZOL-2-YL]-PIPERIDIN-1-YL}-PYRIMIDINE | Metabolex Inc. (US) | 2013-05-01 | — | — | EP | claimed |
| US-20130053468-A1 | COMPOSITION FOR LIQUID CRYSTAL FILM, LIQUID CRYSTAL FILM USING COMPOSITION, AND METHOD OF MANFACTURING LIQUID CRYSTAL FILM | LG CHEM, LTD. (KR) | 2013-02-28 | — | — | US | claimed |
| US-8318043-B2 | Composition for liquid crystal film, liquid crystal film using composition, and method of manufacturing liquid crystal film | LG CHEM, LTD. (KR) | 2012-11-27 | — | — | US | claimed |
| WO-2011163090-A1 | COMPOSITIONS OF 5-ETHYL-2-{4-[4-(4-TETRAZOL-1-YL-PHENOXYMETHYL)-THIAZOL-2-YL]-PIPERIDIN-1-YL}-PYRIMIDINE | METABOLEX, INC. (US) | 2011-12-29 | — | — | WO | claimed |
| US-20110080552-A1 | Composition for liquid crystal film, liquid crystal film using composition, and method of manufacturing liquid crystal film | LG CHEM, LTD. (KR) | 2011-04-07 | — | — | US | claimed |
| CN-1144864-C | Production process of high-smelting point petroleum wax | 中国石油化工股份有限公司 | 2004-04-07 | — | — | CN | claimed |
| CN-1335372-A | Production process of high-smelting point petroleum wax | CHINA PETROCHEMICAL CORP LTD (CN) | 2002-02-13 | — | — | CN | claimed |
| EP-0255303-B1 | NEGATIVE RESIST MATERIAL, METHOD FOR ITS MANUFACTURE AND METHOD FOR USING IT | Oki Electric Industry Company, Limited (JP) | 1989-10-11 | — | — | EP | claimed |
| JP-4044038-A | — | — | None | — | — | JP | disclosed |
| CN-117957494-A | Resin composition, light-shielding film, and substrate with partition wall | 东丽株式会社 | 2024-04-30 | — | — | CN | disclosed |
| US-11827738-B2 | Thiol-ene-curing compositions | MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) | 2023-11-28 | — | — | US | disclosed |
| US-3940414-A | FUNGICIDE, PLANT GROWTH REGULATOR | BAYER AKTIENGESELLSCHAFT (DT) | 1976-02-24 | — | — | US | disclosed |
| US-3934026-A | Combating nematodes with alkanesulfonic acid 2-bromoethyl esters | BAYER AKTIENGESELLSCHAFT (DT) | 1976-01-20 | — | — | US | disclosed |
| US-3931231-A | FUNGICIDE, BACTERICIDE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-01-06 | — | — | US | disclosed |
| US-3931317-A | FUNGICIDE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200148633-A1 | METHOD FOR PREPARING HYDROGEN BIS(FLUOROSULFONYL)IMIDE AND METHOD FOR PREPARING LITHIUM BIS(FLUOROSULFONYL)IMIDE | FHIT, LIFR, FLI1 | ALDH1A1 3296/4885TDP1 2158/4885CA2 1867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.